ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,282, issued on June 24, was assigned to AVEO Pharmaceuticals Inc. (Boston).
"Anti-Notch3 antibody" was invented by Heidi Okamura (Brookline, Mass.), William M. Winston Jr. (Marlborough, Mass.), Laura Poling (Boston) and Alisa C. Bell (Bedford, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Monoclonal antibodies that bind and inhibit activation of human Notch3 are disclosed. The antibodies can be used to treat cell proliferative diseases and disorders, including certain forms of cancer, associated with activation and/or overexpression of Notch3."
The patent was filed on Oct. 7, 2021, under Application No. 17/450,282.
*For further information,...